INS and type 2 diabetes mellitus: In patients with T2D, administration of TZDs successfully improved insulin-stimulated glucose disposal under euglycaemic-hyperinsulinaemic clamp conditions [14,15], where skeletal muscle plays a central glucose-lowering role.